Prevalence and incidence of generalized pustular psoriasis in Sweden: a population-based register study
- PMID: 34978071
- DOI: 10.1111/bjd.20966
Prevalence and incidence of generalized pustular psoriasis in Sweden: a population-based register study
Abstract
Background: Generalized pustular psoriasis (GPP) is a severe form of pustular psoriasis with generalized eruption of sterile pustules, often along with systemic symptoms. There is a scarcity of population-based estimates of GPP prevalence and incidence.
Objectives: To estimate (i) the prevalence and incidence of GPP in the Swedish general population and (ii) the prevalence of psoriasis vulgaris within the GPP population.
Methods: We identified cases (2004-2015) with one ICD-10 diagnostic code (base case) for GPP within the Swedish National Patient Register, which covers inpatient and outpatient secondary care. Cases were linked to the Swedish Total Population Register, and point prevalence was estimated as on 31 December 2015. In two alternative analyses we changed case definitions to: (i) requiring two visits (strict case 1) and (ii) requiring two visits of which one was within dermatology/internal medicine (strict case 2).
Results: The base case point prevalence of GPP was estimated at 9.1 per 100 000 (women, 11.2; men, 7.0) and the annual prevalence in 2015 was estimated at 1.53 per 100 000. Among the GPP population, 43% also had a psoriasis vulgaris code. The incidence of GPP in 2015 was estimated at 0.82 per 100 000 (women, 0.93; men, 0.74). The criteria used had an impact on prevalence and incidence estimates: prevalence strict case 1 gave 3.8 per 100 000 and incidence strict case 1 gave 0.42 per 100 000.
Conclusions: Results indicate that the estimated GPP population in Sweden is within the range of previous published estimates. However, estimates were sensitive to the GPP case criteria used. The findings enhance demands for studies using validated diagnostic algorithms.
© 2022 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.
Similar articles
-
Prevalence and incidence of palmoplantar pustulosis in Sweden: a population-based register study.Br J Dermatol. 2021 Nov;185(5):945-951. doi: 10.1111/bjd.20087. Epub 2021 Jun 27. Br J Dermatol. 2021. PMID: 33792911
-
Incidence and prevalence of generalized pustular psoriasis in multiethnic Johor Bahru, Malaysia: a population-based cohort study using routinely captured electronic health records in the Teleprimary Care (TPC®) clinical information system from 2010 to 2020.Br J Dermatol. 2023 Sep 15;189(4):410-418. doi: 10.1093/bjd/ljad158. Br J Dermatol. 2023. PMID: 37162007
-
Prolonged Sick Leave Before and After Diagnosis of Generalized Pustular Psoriasis: A Swedish Population-based Register Study.Acta Derm Venereol. 2023 Sep 13;103:adv6497. doi: 10.2340/actadv.v103.6497. Acta Derm Venereol. 2023. PMID: 37707292 Free PMC article.
-
Higher Prevalence of Generalized Pustular Psoriasis in Asia? A Population-Based Study Using Claim Data in China and a Systematic Review.Dermatology. 2023;239(2):195-205. doi: 10.1159/000528850. Epub 2023 Jan 2. Dermatology. 2023. PMID: 36592625
-
Generalized pustular psoriasis: practical recommendations for Spanish primary care and emergency physicians.Postgrad Med. 2023 Nov;135(8):766-774. doi: 10.1080/00325481.2023.2285730. Epub 2024 Jan 10. Postgrad Med. 2023. PMID: 38019177 Review.
Cited by
-
Health-related quality of life in patients with generalized pustular psoriasis - a Swedish register study.Ann Med. 2024 Dec;56(1):2341252. doi: 10.1080/07853890.2024.2341252. Epub 2024 May 13. Ann Med. 2024. PMID: 38738413 Free PMC article.
-
Tools to improve the diagnosis and management of T-cell mediated adverse drug reactions.Front Med (Lausanne). 2022 Oct 13;9:923991. doi: 10.3389/fmed.2022.923991. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36313986 Free PMC article. Review.
-
Clinical and Disease Burden of Patients with Generalized Pustular Psoriasis: A Review of Real-World Evidence.Dermatol Ther (Heidelb). 2024 Feb;14(2):341-360. doi: 10.1007/s13555-024-01103-5. Epub 2024 Feb 16. Dermatol Ther (Heidelb). 2024. PMID: 38363460 Free PMC article. Review.
-
Epidemiological, Genetic, Clinical, and Treatment Differences of Generalized Pustular Psoriasis and Acrodermatitis Continua of Hallopeau Across Ethnicities: A Systematic Review.Am J Clin Dermatol. 2025 May;26(3):395-409. doi: 10.1007/s40257-025-00937-9. Epub 2025 Apr 1. Am J Clin Dermatol. 2025. PMID: 40169503
-
Clinical Characteristics of Patients with Pustular Psoriasis: A Single-Center Retrospective Observational Study.Vaccines (Basel). 2022 Jul 23;10(8):1171. doi: 10.3390/vaccines10081171. Vaccines (Basel). 2022. PMID: 35893820 Free PMC article.
References
-
- Kharawala S, Golembesky AK, Bohn RL, Esser D. The clinical, humanistic, and economic burden of generalized pustular psoriasis: a structured review. Expert Rev Clin Immunol 2020; 16:239-52.
-
- Hoegler KM, John AM, Handler MZ, Schwartz RA. Generalized pustular psoriasis: a review and update on treatment. J Eur Acad Dermatol Venereol 2018; 32:1645-51.
-
- Augey F, Renaudier P, Nicolas J-F. Generalized pustular psoriasis (Zumbusch): a French epidemiological survey. Eur J Dermatol 2006; 16:669-73.
-
- Fabbri P. La Psoriasi: dalla Diagnosi alle Terapie. Florence, Italy: SEE, 2004.
-
- Lee JY, Kang S, Park JS et al. Prevalence of psoriasis in Korea: a population-based epidemiological study using the Korean National Health Insurance Database. Ann Dermatol 2017; 29:761-7.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical